Autism spectrum disorder (ASD) is a prevalent neurodevelopmental disorder that appears to have shared genetic and environmental etiologies.1 As the genetic causes have undergone intense investigation, the investigation of specific environmental agents that increase the risk of developing ASD has received less emphasis2 despite the fact that there is growing evidence for environmental factors such as toxicants3 and the enteric microbiome,4, 5, 6 just to name a few. Dr Fluegge, in his letter,7 outlines an interesting environmental influence, which may result in metabolic and behavioral abnormalities associated with ASD.
Nitrous oxide (N2O) is a greenhouse gas which originates, in part, from agriculture, fossil fuel combustion and other industrial sources, which has about 300 times the impact of CO2. Although N2O is a commonly used anesthetic in pediatrics, animal studies have pointed to adverse effects on the developing brain.8 Other studies have implicated N2O as a genotoxin,9 although this effect has been suggested to be indirect,10 perhaps through increases in oxidative stress.11 The animal studies have linked N2O with abnormalities in the maintenance of mitochondrial quality12 and mitochondrial function13 leading to abnormalities in synaptic dynamics in the developing brain.13 However, other epidemiological studies have failed to link it to adverse birth outcomes.14
An important caveat when considering individuals with ASD is that, for many, their metabolic systems appear to be under stress as many demonstrate abnormal redox15 and mitochondrial metabolism.16 In addition, mothers of children with ASD manifest some of these same metabolic abnormalities as their children.17, 18 Indeed, individuals with ASD may be particularly vulnerable to environmental perturbations which affect metabolic systems both prenatally and postnatally. Thus, the role of environmental agents such as N2O may be particularly significant in children with ASD, especially if other underlying conditions exist.
Particularly interesting in the letter from Dr Fluegge is the connection between N2O and the nicotinic alpha 7 cholinergic receptor. Indeed, abnormalities in regulation of the nicotinic alpha 7 cholinergic receptor can lead to autonomic dysfunction and inflammation, both of which are highly associated with ASD.19, 20 In fact, many lines of research have suggested decreased parasympathetic and increased sympathetic drive in many children with ASD, which could explain behavioral features of anxiety and irritability as well as physical symptoms such as chronic constipation.
Clearly, it is possible that children with ASD could be more sensitive to the effect of N2O, and BH4 could mitigate some of these effects by improving redox and nitric oxide metabolism.21 However, at this time, direct empirical evidence is lacking for this theory. Epidemiological studies examining the effect of environmental factors on the risk of developing of ASD have not examined environmental N2O nor has N2O exposure been integrated into an animal model of ASD. Thus, we must await further empirical study to provide a signal as to whether N2O has a significant role in the development or morbidity of ASD.
References
Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011; 68: 1095–1102.
Rossignol DA, Frye RE . A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry 2012; 17: 389–401.
Rossignol DA, Genuis SJ, Frye RE . Environmental toxicants and autism spectrum disorders: a systematic review. Transl Psychiatry 2014; 4: e360.
Frye RE, Rose S, Slattery J, MacFabe DF . Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome. Microb Ecol Health Dis 2015; 26: 27458.
Frye RE, Slattery J, MacFabe DF, Allen-Vercoe E, Parker W, Rodakis J et al. Approaches to studying and manipulating the enteric microbiome to improve autism symptoms. Microb Ecol Health Dis 2015; 26: 26878.
Frye RE, Melnyk S, Macfabe DF . Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder. Transl Psychiatry 2013; 3: e220.
Fluegge K . A reply to Frye RE, DeLatorre R, Taylor HB, Slattery J, Melnyk S, Chowdhury N, James SJ. Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study Transl Psychiatry 2016; 6: e793.
Schmitt EL, Baum VC . Nitrous oxide in pediatric anesthesia: friend or foe? Curr Opin Anaesthesiol 2008; 21: 356–359.
Hogan K . Nitrous oxide genotoxicity. Anesthesiology 2013; 118: 1258–1260.
O'Donovan MR, Hammond TG . Is nitrous oxide a genotoxic carcinogen? Mutagenesis 2015; 30: 459–462.
Wronska-Nofer T, Nofer JR, Jajte J, Dziubaltowska E, Szymczak W, Krajewski W et al. Oxidative DNA damage and oxidative stress in subjects occupationally exposed to nitrous oxide (N(2)O). Mutat Res 2012; 731: 58–63.
Boscolo A, Milanovic D, Starr JA, Sanchez V, Oklopcic A, Moy L et al. Early exposure to general anesthesia disturbs mitochondrial fission and fusion in the developing rat brain. Anesthesiology 2013; 118: 1086–1097.
Sanchez V, Feinstein SD, Lunardi N, Joksovic PM, Boscolo A, Todorovic SM et al. General anesthesia causes long-term impairment of mitochondrial morphogenesis and synaptic transmission in developing rat brain. Anesthesiology 2011; 115: 992–1002.
Shah PS, Balkhair T . Air pollution and birth outcomes: a systematic review. Environ Int 2011; 37: 498–516.
Frye RE, James SJ . Metabolic pathology of autism in relation to redox metabolism. Biomark Med 2014; 8: 321–330.
Rossignol DA, Frye RE . Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 2012; 17: 290–314.
James SJ, Melnyk S, Jernigan S, Pavliv O, Trusty T, Lehman S et al. A functional polymorphism in the reduced folate carrier gene and DNA hypomethylation in mothers of children with autism. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 1209–1220.
Frye RE, Sequeira JM, Quadros EV, James SJ, Rossignol DA . Cerebral folate receptor autoantibodies in autism spectrum disorder. Mol Psychiatry 2013; 18: 369–381.
Benevides TW, Lane SJ . A review of cardiac autonomic measures: considerations for examination of physiological response in children with autism spectrum disorder. J Autism Dev Disord 2015; 45: 560–575.
McDougle CJ, Landino SM, Vahabzadeh A, O'Rourke J, Zurcher NR, Finger BC et al. Toward an immune-mediated subtype of autism spectrum disorder. Brain Res 2015; 1617: 72–92.
Frye RE, Huffman LC, Elliott GR . Tetrahydrobiopterin as a novel therapeutic intervention for autism. Neurotherapeutics 2010; 7: 241–249.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Frye, R., Slattery, J. The potential role of nitrous oxide in the etiology of autism spectrum disorder. Transl Psychiatry 6, e812 (2016). https://doi.org/10.1038/tp.2016.89
Published:
Issue Date:
DOI: https://doi.org/10.1038/tp.2016.89
This article is cited by
-
Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder
Molecular Diagnosis & Therapy (2018)